158 related articles for article (PubMed ID: 26937281)
1. c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia.
Prinzhorn W; Stehle M; Kleiner H; Ruppenthal S; Müller MC; Hofmann WK; Fabarius A; Seifarth W
Biomark Res; 2016; 4():5. PubMed ID: 26937281
[TBL] [Abstract][Full Text] [Related]
2. Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.
Haaß W; Kleiner H; Weiß C; Haferlach C; Schlegelberger B; Müller MC; Hehlmann R; Hofmann WK; Fabarius A; Seifarth W; ;
PLoS One; 2015; 10(6):e0129648. PubMed ID: 26087013
[TBL] [Abstract][Full Text] [Related]
3. Separase activity distribution can be a marker of major molecular response and proliferation of CD34
Spiess B; Kleiner H; Flach J; Fabarius A; Saussele S; Hofmann WK; Seifarth W
Ann Hematol; 2020 May; 99(5):991-1006. PubMed ID: 32253454
[TBL] [Abstract][Full Text] [Related]
4. Measurement of separase proteolytic activity in single living cells by a fluorogenic flow cytometry assay.
Haaß W; Kleiner H; Müller MC; Hofmann WK; Fabarius A; Seifarth W
PLoS One; 2015; 10(8):e0133769. PubMed ID: 26267133
[TBL] [Abstract][Full Text] [Related]
5.
Negi V; Vishwakarma BA; Chu S; Oakley K; Han Y; Bhatia R; Du Y
Oncotarget; 2017 Nov; 8(58):98853-98864. PubMed ID: 29228732
[TBL] [Abstract][Full Text] [Related]
6. [Gene of DNA-dependent protein kinase catalylic subunit in chronic myeloid leukemia].
Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):248-52. PubMed ID: 17493325
[TBL] [Abstract][Full Text] [Related]
7. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
[TBL] [Abstract][Full Text] [Related]
8. Abnormal centrosome-centriole cycle in chronic myeloid leukaemia?
Patel H; Gordon MY
Br J Haematol; 2009 Aug; 146(4):408-17. PubMed ID: 19563513
[TBL] [Abstract][Full Text] [Related]
9. p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
Brusa G; Benvenuti M; Mazzacurati L; Mancini M; Pattacini L; Martinelli G; Barbieri E; Greenberger JS; Baccarani M; Santucci MA
Haematologica; 2003 Jun; 88(6):622-30. PubMed ID: 12801837
[TBL] [Abstract][Full Text] [Related]
10. Separase loss of function cooperates with the loss of p53 in the initiation and progression of T- and B-cell lymphoma, leukemia and aneuploidy in mice.
Mukherjee M; Ge G; Zhang N; Huang E; Nakamura LV; Minor M; Fofanov V; Rao PH; Herron A; Pati D
PLoS One; 2011; 6(7):e22167. PubMed ID: 21799785
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells.
Spagnuolo M; Regazzo G; De Dominici M; Sacconi A; Pelosi A; Korita E; Marchesi F; Pisani F; Magenta A; Lulli V; Cordone I; Mengarelli A; Strano S; Blandino G; Rizzo MG; Calabretta B
Haematologica; 2019 Jan; 104(1):82-92. PubMed ID: 30076175
[TBL] [Abstract][Full Text] [Related]
12. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
Aljedai A; Buckle AM; Hiwarkar P; Syed F
PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
[TBL] [Abstract][Full Text] [Related]
13. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J
J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201
[TBL] [Abstract][Full Text] [Related]
14. Increased separase activity and occurrence of centrosome aberrations concur with transformation of MDS.
Ruppenthal S; Kleiner H; Nolte F; Fabarius A; Hofmann WK; Nowak D; Seifarth W
PLoS One; 2018; 13(1):e0191734. PubMed ID: 29370237
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein.
Neviani P; Santhanam R; Trotta R; Notari M; Blaser BW; Liu S; Mao H; Chang JS; Galietta A; Uttam A; Roy DC; Valtieri M; Bruner-Klisovic R; Caligiuri MA; Bloomfield CD; Marcucci G; Perrotti D
Cancer Cell; 2005 Nov; 8(5):355-68. PubMed ID: 16286244
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
[TBL] [Abstract][Full Text] [Related]
17. Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients.
Bussolari R; Candini O; Colomer D; Corradini F; Guerzoni C; Mariani SA; Cattelani S; Silvestri C; Pecorari L; Iacobucci I; Soverini S; Fasano T; Martinelli G; Cervantes F; Calabretta B
Leuk Res; 2007 Feb; 31(2):163-7. PubMed ID: 16797705
[TBL] [Abstract][Full Text] [Related]
18. Proteome changes induced by c-myb silencing in human chronic myeloid leukemia cells suggest molecular mechanisms and putative biomarkers of hematopoietic malignancies.
Di Carli M; Tanno B; Capodicasa C; Villani ME; Salzano AM; Scaloni A; Raschellà G; Benvenuto E; Donini M
J Proteomics; 2014 Jan; 96():200-22. PubMed ID: 24220303
[TBL] [Abstract][Full Text] [Related]
19. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
20. A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells.
Chen CW; Lee YL; Liou JP; Liu YH; Liu CW; Chen TY; Huang HM
Apoptosis; 2016 Sep; 21(9):1008-18. PubMed ID: 27344662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
